351,305 results on '"Prostate cancer"'
Search Results
302. To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence
303. Infective Complications in TP Biopsy Without Antibiotic Prophylaxis
304. CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer (CREATIVE)
305. Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial
306. Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging (DLRPRO)
307. A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
308. A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer (CAPTAIN)
309. Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project (ASCAPE)
310. Study of PCUR-101 in Combination With ADT in Patients With mCRPC
311. Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.
312. Real World Prostate Cancer Registry (RWPCR)
313. Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer (ultraHART)
314. New Urethral Reconstruction in Robot-assisted Laparoscopic Radical Resection
315. Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
316. Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy (CARLHA-2)
317. A Study of Olaparib and Durvalumab in Prostate Cancer
318. Effect of Optimized PEEP on Mechanical Ventilation During Robot Assisted Laparoscopic Prostatectomy
319. A Web-based Peer Navigation Program for Men With Prostate Cancer
320. A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
321. Lifestyle Intervention in Patients With Metastatic Prostate Cancer (ACTIDIET-PRO)
322. Ultrasound for Detection of Prostate Cancer (SURF)
323. PRISMA-PET - Primary Staging of Prostate Cancer With PSMA
324. First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine
325. A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
326. ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer
327. Phase III Radium 223 mCRPC-PEACE III (PEACE III)
328. Modified Radical Prostatectomy for Prostate Cancer Patients With Enlarged Prostate and Severe Lower Urinary Tract Symptoms: a Single-center, Retrospective Study (Two-step RP)
329. Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
330. Validating the 'Sexual Minorities and Prostate Cancer Scale' to Gold Standard Questionnaires (SMACS)
331. Randomized Controlled Trial of MRI Target Biopsy: Transrectal vs. Transperineal
332. High Resolution MRI Study for Prostate Cancer
333. Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer (PEGASUS)
334. Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer
335. Prostate Cancer Screening: a Pilot Study (ProScreenMRI)
336. Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial) (ExBAT)
337. ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
338. Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
339. NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
340. Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
341. A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
342. An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CheckMate 9KD)
343. A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients
344. Addition of cribriform pattern 4 and intraductal prostatic carcinoma into the CAPRA-S tool improves post-radical prostatectomy patient stratification in a multi-institutional cohort
345. Understanding Spatial Correlation Between Multiparametric MRI Performance and Prostate Cancer
346. Targeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy
347. Impact of PSMA PET on Prostate Cancer Management
348. Safety of high-dose-rate brachytherapy in patients with prostate cancer and inflammatory bowel disease: A case series.
349. PSMA PET/CT and mpMRI discrepancies in prostate cancer detection with whole-mount histopathology gold standard.
350. Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.